Clinical Trial Update: Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of Jaktinib in active Ankylosing spondylitis is ongoing and currently listed as active not recruiting,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Jaktinib (jaktinib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Ankylosing Spondylitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING